Eirini Vasarmidi
Overview
Explore the profile of Eirini Vasarmidi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
569
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Vasarmidi E, Hindre R, Uzunhan Y, Borie R, Crestani B
Rheumatol Adv Pract
. 2022 Aug;
6(2):rkac063.
PMID: 35975127
No abstract available.
12.
Vasarmidi E, Ghanem M, Crestani B
Curr Opin Pulm Med
. 2022 Aug;
28(5):399-406.
PMID: 35938200
Purpose Of Review: The aim of this review was to summarize the recent data concerning interstitial lung disease after COVID-19, a field where knowledge is evolving very quickly. Recent Findings:...
13.
Justet A, Ghanem M, Boghanim T, Hachem M, Vasarmidi E, Jaillet M, et al.
Am J Respir Cell Mol Biol
. 2022 May;
67(2):173-187.
PMID: 35549849
Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease with limited therapeutic possibilities. FGF19 (fibroblast growth factor 19), an endocrine FGF, was recently shown to decrease liver fibrosis. To ask...
14.
Mkacher R, Jaillet M, Colicchio B, Vasarmidi E, Mailleux A, Dieterlen A, et al.
Biomedicines
. 2022 Feb;
10(2).
PMID: 35203522
Idiopathic pulmonary fibrosis (IPF) is associated with several hallmarks of aging including telomere shortening, which can result from germline mutations in telomere related genes (TRGs). Here, we assessed the length...
15.
Antoniou K, Vasarmidi E, Russell A, Andrejak C, Crestani B, Delcroix M, et al.
Eur Respir J
. 2022 Feb;
60(2).
PMID: 35144991
Patients diagnosed with coronavirus disease 2019 (COVID-19) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection frequently experience symptom burden post-acute infection or post-hospitalisation. We aimed to identify optimal...
16.
Tsitoura E, Trachalaki A, Vasarmidi E, Mastrodemou S, Margaritopoulos G, Kokosi M, et al.
Front Immunol
. 2021 Dec;
12:645548.
PMID: 34867934
Within the Interstitial Lung Diseases (ILD), patients with idiopathic pulmonary fibrosis (IPF) and a subset of those with non-IPF fibrotic ILD have a distinct clinical phenotype of progression despite management....
17.
Bizymi N, Pitsidianakis G, Ierodiakonou D, Stathakis G, Vasarmidi E, Hiraki S, et al.
Front Med (Lausanne)
. 2021 Aug;
8:673573.
PMID: 34434942
Acute fibrinous and organizing pneumonia (AFOP) is an entity that can be secondary to various conditions leading to lung injury, such as infections, malignancies, and various autoimmune conditions or idiopathic...
18.
Pitsidianakis G, Vassalou E, Vasarmidi E, Bolaki M, Klontzas M, Xirouchaki N, et al.
J Ultrasound Med
. 2021 Jul;
41(5):1077-1084.
PMID: 34291845
Objectives: In this study, we sought to assess the validity of lung ultrasound (LUS) during the follow-up of patients with a wide spectrum of interstitial lung diseases (ILDs). Methods: Twenty-four...
19.
Trachalaki A, Tsitoura E, Mastrodimou S, Invernizzi R, Vasarmidi E, Bibaki E, et al.
Front Immunol
. 2021 Jul;
12:661811.
PMID: 34220810
Fibrotic Interstitial lung diseases (ILDs) are complex disorders of variable clinical behaviour. The majority of them cause significant morbidity, whilst Idiopathic Pulmonary Fibrosis (IPF) is recognised as the most relentless....
20.
Karampitsakos T, Torrisi S, Antoniou K, Manali E, Korbila I, Papaioannou O, et al.
Respir Res
. 2021 May;
22(1):140.
PMID: 33952261
Background: Idiopathic Pulmonary Fibrosis (IPF) represents a chronic lung disease with unpredictable course. Methods: We aimed to investigate prognostic performance of complete blood count parameters in IPF. Treatment-naïve patients with...